AAPL 179.06 +0.32 (+0.18%)MSFT 126.11 +0.03 (+0.02%)FB 181.06 +0.03 (+0.02%)ZNGA 6.06 -0.02 (-0.33%)NVDA 144.95 -0.07 (-0.05%)WBA 51.77 +0.01 (+0.02%)GOOG 1133.33 +0.71 (+0.06%)PIH 5.61 -0.09 (-1.58%)
AAPL 179.06 +0.32 (+0.18%)MSFT 126.11 +0.03 (+0.02%)FB 181.06 +0.03 (+0.02%)ZNGA 6.06 -0.02 (-0.33%)NVDA 144.95 -0.07 (-0.05%)WBA 51.77 +0.01 (+0.02%)GOOG 1133.33 +0.71 (+0.06%)PIH 5.61 -0.09 (-1.58%)

Financial Summary DOVA Quote Dova Pharma

Dova Pharmaceuticals Inc. Quote

Dova Pharmaceut (DOVA)

9.92 0.14 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C-
Symbol DOVA
Price 9.92
Beta 2.04
Vol Avg 176.23 K
Mkt cap 275.81 M
Shares Not Available
Last Div Not Available
Div Yield Not Available
DCF Unlevered 0.00
DCF Levered 0.00
ROE 0.00% Neutral
ROA 0.00% Neutral
Operating Margin Not Available
Debt/Equity 314.29% Strong Buy
P/E 0.00
P/B 0.00 Neutral
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 0 0 0 0
COGS 0 0 0 0 1
GrossProfit 0 0 0 0 9
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 0 0 0 6 12
ResearchAndDeve 0 0 0 16 18
SalesGeneralAnd 0 0 0 13 62
OperatingIncome 0 0 0 -29 -71
InterestExpense 0 0 0 1 2
OtherIncome 0 0 0 0 1
IncomeBeforeTax 0 0 0 -30 -72
ProvisionForInc 0 0 0 0 0
NetIncome 0 0 0 -30 -72
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 0 0 29 95 105
ShortTermInvest 0 0 0 0 0
Cash 0 0 29 0 0
AccountReceivab 0 0 0 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 0 0 29 96 112
PPE 0 0 0 0 0
AccumulatedDepr 0 0 0 0 0
NetPPE 0 0 0 0 0
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 0 0 0 0 0
TotalAssets 0 0 29 96 112
ShortTermDebt 0 0 0 30 7
AccountsPayable 0 0 0 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 0 8 0 0
DeferredRevenue 0 0 0 0 2
OtherCurrentLia 0 0 0 0 2
TotalCurrentLia 0 0 8 35 19
Debt 0 0 14 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 0 0 0 0 0
TotalNonCurrent 0 0 14 0 16
TotalLiabilitie 0 0 22 35 36
CommonStock 0 0 0 0 0
AdditionalPaidI 0 0 34 118 206
RetainedEarning 0 0 -27 -57 -129
AccumulatedOthe 0 0 0 0 0
TotalStockholde 0 0 7 61 76
TotalLiabilitie 0 0 29 96 112
Cash Flow Statement
Year 20142015201620172018
NetIncome 0 0 0 -30 -72
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 0 0 6 12
AccountsReceiva 0 0 0 0 -1
InventoryCS 0 0 0 0 -4
AccountsPayable 0 0 0 1 0
OtherWorkingCap 0 0 0 -1 3
OtherNonCashIte 0 0 0 11 1
NetCashProvided 0 0 0 -11 -54
InvestmentsInPP 0 0 0 0 0
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 0 0
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 -1 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 0 0 0 -1 0
DebtIssued 0 0 0 0 20
DebtRepayment 0 0 0 0 -31
CommonStockIssu 0 0 0 86 80
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 0 0 -8 -5
NetCashProvided 0 0 0 78 64
NetChangeInCash 0 0 0 66 10
CashAtBeginning 0 0 0 29 95
CashAtEndOfPeri 0 0 0 95 105
Retained Earnings
Year 20142015201620172018
RetainedEarning -----
NetIncome -----
StockDividend ----27
DividendPaid -----
RetainedEarning -----27
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE -----
DeprAnnual 0----
CapitalExpendit 00000
NetPPE -----
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0----
NewPurchases 0----
intAndGW -----
Company Profile

CEO

Alex Sapir

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

Dova Pharmaceuticals Inc is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia.